🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud of this work presented by our student Lillian King at the RSA #rsa2024 co-mentored by Lorenzo Leggio investigating ultra-processed food (UPF) consumption in people with alcohol use disorder #NIH_TBHD ⁦NIH Clinical Center⁩ ⁦Mehdi Farokhnia مهدی فرخ‌نیا⁩ ⁦NIDAnews⁩ ⁦

our longitudinal study is out! this took the effort of many people over many years, and of course the funding from NIAAA News. congrats Kate Kirk-Provencher, PhD :) Neural responses to reward, threat, and emotion regulation and transition to hazardous alcohol use academic.oup.com/alcalc/article…

NIAAA News Kate Kirk-Provencher, PhD it was my first time publishing with Alcohol and Alcoholism via Oxford Academic and it was a great journal to work with, thanks editor Lorenzo Leggio !

🚨 Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target sciencedirect.com/science/articl… Lorenzo Leggio Pharmacological Research NIDAnews NIAAA News NIH Intramural

Review of the week: excellent 2008 review on social stress and addiction to commemorate the career of Klaus Miczek, who died this week. Klaus published many exceptional papers on aggression, stress, and addiction, and his work has inspired many of us pubmed.ncbi.nlm.nih.gov/18789966/

Also here Lorenzo Leggio discusses his keynote called "Mind the gut: Developing new treatments for Alcohol Use Disorder"

Register for NASEM Health’s #NeuroForum workshop on 9/10 exploring potential applications of #GLP1R medications in the treatment of central nervous system disorders, such as Parkinson’s disease and substance use disorders: ow.ly/ffOI50SOZgI

The American Journal of Drug and Alcohol Abuse has released a special collection of articles on COVID-19's impact on substance use. Dive into the latest research to understand how the pandemic has shaped addiction and recovery. tandfonline.com/journals/iada2…

Our systematic review on the effect of alcohol, tobacco, and other drug use on #vaccine acceptance, uptake, and adherence was published!💉🎉🧠Huge thank you to Lorenzo Leggio and my NIDA NIH Intramural team members🫶 Link to full text⬇️ doi.org/10.1093/alcalc… NIDAnews NIAAA News

We are ready and excited to learn how we can move forward alcohol-related research and care at YCARE 2024! Register to join us tomorrow! Yale Digestive Diseases Yale Internal Medicine Yale School of Medicine NIAAA News Yale Psychiatry Yale School of Public Health Yale Program in Addiction Medicine Cornell Scott HHC yalesurvey.ca1.qualtrics.com/jfe/form/SV_a3…

#Ozempic has attracted public interest over the last few years for weight loss and management. However, scientists are exploring a different use for the once low-profile diabetes medication. Dr. Lorenzo Leggio (Lorenzo Leggio) at NIDAnews is studying how Ozempic can be used to

Don’t miss this December ENTIRE issue of HEPATOLOGY Journal dedicated to #ALD Presented here by Dr. Michael R. Lucey UW School of Medicine and Public Health AASLD Watch: buff.ly/41JYkRG

🚨 A randomized, double-blind, placebo-controlled study of a GHSR blocker in people with alcohol use disorder insight.jci.org/articles/view/… NIH Intramural NIDAnews NIAAA News JCI insight MONICA FAULKNER Brittney Browning Allison Daurio, PhD Vikas Munjal @IAmSusanPersky Lorenzo Leggio

Phase 2a experimental medicine study in alcohol use disorder (AUD) provides some of the first human evidence of GHSR blockade PF-5190457's role in food selection behavior. Study by M. Faulkner, M. Farokhnia, M. Lee , L. Farinelli B. Browning , K. Abshire, A. Daurio, V. Munjal, S.

🚨 Bariatric surgery and alcohol and substance use: A case-control survey study sciencedirect.com/science/articl… NIH Intramural NIDAnews NIAAA News Lorenzo Leggio Claire Pince @sal_giorgi @B_Curtis03 @DrugAlcoholDep

🚨 Glucagon-like peptide-1 receptor agonists but not dipeptidyl peptidase-4 inhibitors reduce alcohol intake. Super proud of this work supported by and done at NIH. NIH Intramural NIDAnews NIAAA News Christopher T. Rentsch Lorenzo Leggio Journal of Clinical Investigation jci.org/articles/view/…

Findings by #NIH/#NIAAA researchers led by Dr. Lorenzo Leggio suggest GLP-1R agonists can be effective to reduce AUDIT-C scores, and that reductions in drinking are more pronounced among individuals with alcohol use disorder. Read the article: jci.org/articles/view/…

Interested in learning more about research at NIDA in Baltimore, MD? NIDA welcomes participants to join our ongoing research studies. Go to our Research Studies page and click “Find a study” to learn more! go.nih.gov/Rm1CAfB

Interested in learning more about research at NIDA in Baltimore, MD? NIDA welcomes participants to join our ongoing research studies. Go to our Research Studies page and click “Find a study” to learn more! go.nih.gov/Rm1CAfB